Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications

J Ren, NN Wu, S Wang, JR Sowers… - Physiological …, 2021 - journals.physiology.org
The prevalence of heart failure is on the rise and imposes a major health threat, in part, due
to the rapidly increased prevalence of overweight and obesity. To this point …

Meta-analysis of penetrance and systematic review on transition to disease in genetic hypertrophic cardiomyopathy

CC Topriceanu, AC Pereira, JC Moon, G Captur… - Circulation, 2024 - Am Heart Assoc
BACKGROUND: Hypertrophic cardiomyopathy (HCM) is characterized by unexplained left
ventricular hypertrophy and is classically caused by pathogenic or likely pathogenic variants …

Obesity and COVID-19 pandemics: epidemiology, mechanisms, and management

Y Yang, Y Song, D Hou - Diabetes, Metabolic Syndrome and …, 2023 - Taylor & Francis
Obesity is a principle causative factor of various metabolic dysfunctions, chronic
inflammation, and multi-organ impairment. The global epidemic of obesity has constituted …

[HTML][HTML] Western diet triggers cardiac dysfunction in heterozygous Mybpc3-targeted knock-in mice: a two-hit model of hypertrophic cardiomyopathy

EE Nollet, S Algül, M Goebel, S Schlossarek… - Journal of Molecular and …, 2023 - Elsevier
Background and aim Phenotypic expression of hypertrophic cardiomyopathy (HCM) and
disease course are associated with unfavorable metabolic health. We investigated if …

Comprehensive multicomponent cardiac rehabilitation in cardiac implantable electronic devices recipients: a consensus document from the European Association of …

RFE Pedretti, MC Iliou, CW Israel… - European journal of …, 2021 - academic.oup.com
Cardiac rehabilitation (CR) is a multidisciplinary intervention including patient assessment
and medical actions to promote stabilization, management of cardiovascular risk factors …

Association between renin–angiotensin–aldosterone system blockade and clinical outcomes in patients with hypertension: real-world observation from a nationwide …

CS Park, B Kim, TM Rhee, HJ Lee, HS Lee… - Clinical Research in …, 2023 - Springer
Objective We investigated the association between the use of ACEi, ARB, or non-renin–
angiotensin–aldosterone system inhibitors (non-RASi) and incident cardiovascular events in …

Phenotypic Spectrum of Subclinical Sarcomere-Related Hypertrophic Cardiomyopathy and Transition to Overt Disease

CC Topriceanu, JC Moon, A Axelsson Raja… - Circulation: Genomic …, 2024 - ahajournals.org
Genetic hypertrophic cardiomyopathy (HCM) is classically caused by pathogenic/likely
pathogenic variants in sarcomere genes (G+). Currently, HCM is diagnosed if there is …

Unraveling the genotype‐phenotype relationship in hypertrophic cardiomyopathy: obesity‐related cardiac defects as a major disease modifier

EE Nollet, BD Westenbrink, RA de Boer… - Journal of the …, 2020 - Am Heart Assoc
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiomyopathy and is
characterized by asymmetric septal thickening and diastolic dysfunction. More than 1500 …

Comparison of mortality and cause of death between adults with and without hypertrophic cardiomyopathy

S Kwon, HK Kim, B Kim, HJ Lee, KD Han, IC Hwang… - Scientific Reports, 2022 - nature.com
Insufficient evidence is available comparing mortality and cause of death between general
hypertrophic cardiomyopathy (HCM) and general non-HCM populations. We aimed to …

[HTML][HTML] Association between cardiovascular risk factors and dilated and hypertrophic cardiomyopathy: Mendelian randomization analysis

C Zou, H Zou, Y Jiang, S Lai, J Liu - Nutrition, Metabolism and …, 2025 - Elsevier
Background and aims: Dilated cardiomyopathy is a major cause of heart failure, and
hypertrophic cardiomyopathy is a common cause of sudden cardiac death in young adults …